CombiMatrix Names Trilochan Sahoo, M.D., Director of Cytogenetics (CombiMatrix Corporation)

(Source: CombiMatrix Corporation) CombiMatrix Names Trilochan Sahoo, M.D., Director of Cytogenetics Company Continues to Strengthen Medical Team and Sales Force to Manage Growth IRVINE, Calif., April 9, 2014 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (Nasdaq:CBMX), a molecular diagnostics company specializing in DNA-based testing services for developmental disorders and cancer diagnostics, today announced that Trilochan Sahoo, M.D. FACMG, has recently joined the Company as Director of Cytogenetics. Dr. Sahoo will report to Wes Tyson, M.D., Chief Medical Officer of CombiMatrix. Dr. Sahoo, 50, has spent most of his career involved in the development, evaluation and implementation of...